Stock Market News2 days Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study Zacks
NBTX stock rises following initiation of dosing in a mid-stage NSCLC study evaluating a potential first-in-class radioenhancer, JNJ-1900.
Johnson & Johnson (JNJ) · Premarket
X